K
K. de Vlam
Researcher at Katholieke Universiteit Leuven
Publications - 93
Citations - 5639
K. de Vlam is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 24, co-authored 58 publications receiving 5064 citations.
Papers
More filters
Journal ArticleDOI
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
Rabia Agca,Sjoerd C. Heslinga,Silvia Rollefstad,Maaike Heslinga,Iain B. McInnes,Mike J L Peters,Tore K Kvien,Maxime Dougados,Helga Radner,Fabiola Atzeni,Jette Primdahl,Anna Södergren,S. Wallberg Jonsson,J. van Rompay,Condruta Zabalan,Terje R. Pedersen,Lennart T H Jacobsson,K. de Vlam,Miguel A. Gonzalez-Gay,Anne Grete Semb,George D. Kitas,Yvo M. Smulders,Zoltán Szekanecz,Naveed Sattar,Deborah P M Symmons,Michael T. Nurmohamed +25 more
TL;DR: The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased, which underscores the need for CVDrisk management in these patients.
Journal ArticleDOI
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal
Martin Rudwaleit,Robert Landewé,D. van der Heijde,Joachim Listing,J Brandt,Jürgen Braun,Rubén Burgos-Vargas,Eduardo Collantes-Estevez,John A. Davis,Ben A. C. Dijkmans,Maxime Dougados,Paul Emery,I E van der Horst-Bruinsma,Robert D. Inman,M A Khan,Marjatta Leirisalo-Repo,S van der Linden,Walter P. Maksymowych,Herman Mielants,I. Olivieri,Roger D. Sturrock,K. de Vlam,Joachim Sieper +22 more
TL;DR: The ASAS group has developed candidate criteria for the classification of axial SpA that include patients without radiographic sacroiliitis, and the candidate criteria need to be validated in an independent international study.
Journal ArticleDOI
Treatment recommendations for psoriatic arthritis
Christopher T. Ritchlin,Arthur Kavanaugh,Dafna D. Gladman,Philip J. Mease,Philip S. Helliwell,Wolf-Henning Boehncke,K. de Vlam,David Fiorentino,Oliver FitzGerald,Alice B. Gottlieb,Neil McHugh,Peter Nash,Abrar A. Qureshi,Enrique R. Soriano,William J. Taylor +14 more
TL;DR: Treatment recommendations for the cardinal physical manifestations of PsA were developed based on a literature review and consensus between rheumatologists and dermatologists and a grid was established to assist in therapeutic reasoning and decision making for individual patients.
Journal ArticleDOI
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni,Gerald G. Krueger,K. de Vlam,C. Birbara,A. Beutler,Cynthia Guzzo,B. Zhou,Lisa T. Dooley,Arthur Kavanaugh +8 more
TL;DR: Infliximab 5 mg/kg through 24 weeks significantly improved active PsA, including dactylitis and enthesopathy, and associated psoriasis.
Journal ArticleDOI
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
Laure Gossec,Josef S. Smolen,Cécile Gaujoux-Viala,Zoe Ash,Helena Marzo-Ortega,D. van der Heijde,Oliver FitzGerald,Daniel Aletaha,Peter V. Balint,Dimitrios T. Boumpas,Jürgen Braun,F. C. Breedveld,G.-R. Burmester,Juan D. Cañete,M. de Wit,Hanne Dagfinrud,K. de Vlam,Maxime Dougados,P S Helliwell,A. Kavanaugh,Tore K Kvien,Robert Landewé,Thomas A. Luger,Mara Maccarone,Dennis McGonagle,Neil McHugh,Iain B. McInnes,Christopher T. Ritchlin,J. Sieper,Paul P. Tak,Guido Valesini,Jiri Vencovsky,Kevin L. Winthrop,Angela Zink,Paul Emery +34 more
TL;DR: These recommendations are intended to provide rheumatologists, patients and other stakeholders with a consensus on the pharmacological treatment of PsA and strategies to reach optimal outcomes, based on combining evidence and expert opinion.